Trial intelligence / Profile preview

Indocyanine green for intraoperative lymphatic mapping in colorectal cancer surgery

jRCTs031220639Completed

Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green in colorectal cancer (CRC). Primary endpoint: Rate of subjects with resection line changed from baseline due to ICG fluorescence. Started Sep 2023; status: completed.

02

Drugs

indocyanine green
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on jRCTs031220639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call